SlideShare a Scribd company logo
1 of 4
Download to read offline
Vol. 10, No. 9MOLECULAR AND CELLULAR BIOLOGY, Sept. 1990, p. 5011-5014
0270-7306/90/095011-04$02.00/0
Functional State of the Epidermal Growth Factor-Receptor
Complexes during Their Internalization in A-431 Cells
ALEXANDER NESTEROV,* GALINA RESHETNIKOVA, NINA VINOGRADOVA, AND NIKOLAY NIKOLSKY
Institute of Cytology of the Academy of Sciences of the USSR, Tikhoretsky pr. 4, Leningrad 194064, USSR
Received 13 February 1990/Accepted 21 June 1990
Functional state of internalized epidermal growth factor (EGF) receptor in A431 cells has been studied. The
use of photoaffinity [12"I]EGF derivative allowed us to establish that inside the cell the EGF retains its
connection with the receptor. With the help of polyclonal antibodies to phosphotyrosine, it has been shown that
EGF-receptor complexes maintain their phosphorylated state during internalization. The internalized EGF
receptor kinase as well as that localized in the plasma membrane appeared to be able to phosphorylate synthetic
peptide substrate introduced into the cell.
The epidermal growth factor (EGF) receptor is a 170-
kilodalton (kDa) integral membrane glycoprotein containing
cytosol-oriented tyrosine-specific kinase (for a review, see
reference 18). EGF binding stimulates receptor tyrosine
kinase, resulting in both receptor and substrate phosphory-
lation (for a review, see reference 10). There is a lot of data
showing that receptor kinase activity plays an important role
in the transmission of mitogenic signal (for a review, see
references 20 and 25).
After EGF binding, the ligand-receptor complexes are
rapidly internalized; they are then delivered to various
endosomal structures and, finally, degraded within lyso-
somes (8, 9, 12, 21, 22). The role of the internalization
process in triggering the biochemical reactions leading to
DNA synthesis so far remains obscure. To elucidate this
question, the functional state of internalized EGF receptor
should be determined.
Whether the EGF receptors retain their functional activity
during the translocation from plasma membrane into endo-
somal compartment is yet to be clarified. Thus, the presence
of active EGF receptor in the fractions of intracellular
components isolated from homogenates of A-431 cells (5)
and rat liver cells (13) has been shown. On the other hand,
from the results of experiments on intact A-431 cells, Sturani
and co-workers concluded that internalized EGF receptors
failed to maintain the phosphorylated state of tyrosine resi-
dues (24). In this study, we compared the functional state of
internalized and membrane-localized EGF-receptor com-
plexes by using two experimental approaches: (i) cell ex-
posure to EGF at low temperature, which is known to
completely block internalization (1) and (ii) removal of
surface-bound EGF by cell treatment with weak acid buffer
(50 mM sodium acetate [pH 4.5 to 5.0] containing 150 mM
NaCl). To identify phosphotyrosine-containing proteins, we
have used affinity-purified polyclonal antibody to phospho-
tyrosine (anti-P-Tyr). As has been established previously,
the major phosphoprotein interacting with this antibody in
the EGF-stimulated A-431 cells is the EGF receptor (17).
Effect of mild acid wash on EGF receptor Tyr phosphory-
lation. In two parallel series of experiments, the cells were
preincubated with EGF at 4°C and then placed at 37 or 4°C
for an hour. During this period of incubation at 37°C, from 60
to 75% of cell-associated [125I]EGF was found to be inter-
*
Corresponding author.
nalized (data not shown). After the incubation with EGF,
some ofthe cultures were subjected to acid treatment. In the
first series of experiments (Fig. 1), the cells were metaboli-
cally labeled with [32P]orthophosphate and Tyr-phosphory-
lated receptors were detected by immunoprecipitation with
anti-P-Tyr, while in the second series of experiments the
receptors were detected by immunofluorescence staining
(Fig. 2). Sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis of immunoprecipitated proteins has shown that at
4°C, EGF markedly stimulates Tyr phosphorylation of a
170-kDa protein corresponding to the known molecular mass
of EGF receptor (2). Under such conditions, immunostain-
ing is observed along the cell margins, which is a typical
pattern for the distribution of membrane receptors (8, 21,
22). Removal ofthe surface-bound EGF by acid treatment of
the cells incubated with EGF at 4°C resulted in rapid
receptor dephosphorylation. In contrast, in the case of
incubation of cells at 37°C, when internalization took place,
such acid treatment did not result in any significant decre-
ment of phosphotyrosine content in the receptor molecule,
which indicates that during internalization the receptors
remain Tyr phosphorylated. Immunofluorescence analysis
shows that inside the cell, phosphorylated receptors are
mainly concentrated in the juxtanuclear area which has
earlier been identified as the para-Golgi region (22).
Photoaffinity labeling of the EGF receptor. To prepare the
photoaffinity EGF derivative, [1251I]EGF was coupled to the
heterobifunctional reagent N-5-azido-2-nitrobenzoyloxysuc-
cinimide (Sigma Chemical Co.) as described by Hock and
co-workers (11). The cells were allowed to internalize pho-
toaffinity [125I]EGF, and then some of the cultures were
subjected to acid treatment. At the end of the procedure
described in detail in the legend to Fig. 3, the cells were UV
irradiated to provoke ['25I]EGF-receptor covalent coupling.
After that, the cells were solubilized and two equivalent
portions of each extract were analyzed. One of them was
immunoprecipitated with anti-P-Tyr, and then both the im-
munoprecipitate and the total extract were processed by
electrophoresis. Radioactivity corresponding to 175-kDa
bands and total cell-associated radioactivity were measured.
The immunoprecipitation efficiency determined by the addi-
tional immunoprecipitation from the same extract with a new
portion of anti-P-Tyr appeared to be equal to 90% (data not
shown). In control experiments, when the internalization
was blocked by low temperature (Fig. 3, lanes a), the acid
treatment resulted in a strong decrease in the radioactivity of
5011
MOL. CELL. BIOL.
40C 37°C 4°C 370C
a bc d e f
* 4113-170
FIG. 1. Effect of mild acid wash on the phosphotyrosine content
in internalized EGF receptors and those located in the plasma
membrane. Cells were labeled with [32P]orthophosphate and ex-
posed to 200 ng of EGF per ml (lanes b, c, e, and f) or EGF-free
medium (lanes a and d) for an hour at 4°C. Then, some of the
cultures in the same medium were placed at 37°C for an hour (lanes
d, e, and f), while the others were left at 4°C (lanes a, b, and c). After
incubation, the cells were either immediately extracted (lanes a, b,
d, and e) or washed with the acid (lanes c and f). Phosphotyrosine-
containing proteins were immunoprecipitated with 20 ,ug of anti-P-
Tyr, separated by sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis, and identified by autoradiography. Molecular size, in
kilodaltons, is shown on the right.
175-kDa bands. The data suggest that lack of sensitivity of
photoaffinity [1251I]EGF to acid treatment indicates its intra-
cellular location and is not due to spontaneous covalent
ligand-receptor coupling.
Using photoaffinity [1251]EGF derivative, we analyzed
EGF-receptor interactions directly within endosomes. Com-
parison of lanes b and c in Fig. 3 shows that acid treatment
results in the same decrease in the radioactivity of both
175-kDa bands and in the total cell-associated radioactivity.
These results show that the photoaffinity [1251]EGF attach to
the receptors in endosomes as effectively as in plasma
membrane, which indicates that during internalization no
significant dissociation of ligand-receptor complexes occurs.
The data obtained are in agreement with electron micros-
copy observations (3, 16) and our previous results on cells
permeabilized with detergent (21). It should be noted that the
slow degradation kinetics of EGF-receptor complexes is a
peculiarity of A-431 cells (15). For instance, in human
diploid fibroblasts, receptor degradation is much more rapid
(23).
The immunoprecipitation of covalent [125I]EGF-receptor
complexes has shown that only about 15% of them are
capable of interacting with anti-P-Tyr, which points to
functional heterogeneity of the EGF receptor population in
A-431 cells. King and Cooper (14), as well as Sturani and
co-workers (24), came to the same conclusion by using other
experimental approaches. As has been found previously for
the insulin receptor (19), it can be assumed that there are at
least two EGF receptor subpopulations which differ in
phosphorylation state. The fact that the percentage of ty-
rosine-phosphorylated receptors remains unchanged during
internalization shows that inside the cell, the receptors are
not affected by dephosphorylation.
FIG. 2. Immunofluorescent staining of A-431 cells with anti-P-
Tyr. Cells on cover slips were incubated with EGF and washed as
described in the legend to Fig. 1. At the end of the procedure, cells
were fixed with 4% formaldehyde, permeabilized with 0.1% Triton
X-100, and stained with anti-P-Tyr. The second antibodies used
were fluorescein isothiocyanate-conjugated goat anti-rabbit immu-
noglobulin G. Lanes in Fig. 1 correspond to the panels in Fig. 2. Bar,
50 pm.
Evaluation of receptor kinase activity. In the experiments
on the intact cells, the protein kinase activity of internalized
EGF receptor was indirectly estimated by the phosphoty-
rosine content in the receptor molecule (3, 24). However, the
amount of phosphorylated receptors depends on at least two
additional factors which can vary during the internalization:
(i) the tyrosine phosphatase activity in the cell interior and
(ii) the competition for tyrosine kinase between different
intracellular substrates, on one side, and receptor autophos-
phorylation sites, on the other. Consequently, the direct
method should be employed to evaluate the activity of the
EGF receptor tyrosine kinase during endocytosis. For this
purpose, the exogenous tyrosine kinase substrate and
[-y-32P]ATP were introduced by mild digitonine permeabili-
zation into the cells treated as described in the legend to Fig.
4. After the cells were treated, the EGF-stimulated tyrosine
kinase activity was assayed. The reaction was carried out as
described by Giugni and co-workers (7), except that the
reaction mixture was supplemented with synthetic peptide.
Briefly, the phosphorylation reaction was initiated by the
addition of reaction mixture containing 50 ,uM [-y-32P]ATP,
the synthetic peptide substrate for tyrosine kinase (1 mg/ml),
and 0.01% digitonine. Phosphorylation was allowed to pro-
ceed for 10 min at 4°C, after which the reaction was
terminated by the addition of an equal volume of a double
5012 NOTES
VOL.10,1990~~~~~~~~~~~~~~~~~~NOTES5013
Pc
A
IL --_J
I
a --
B
a b cd
Ibe--c 1
d I
a.-
Snesad~f
'.4
0
-;50.4)
.0
C;
a b a d
FIG. 3. Photoaffinity labeling of EGF receptor. The cells were
preexposed to photoaffinity [1251]IEGF (200 ng/ml) at 40C and then
placed at 370C for an hour (lanes b, c, and d), while the control
cultures (lanes a) were left at 40C. At the end of incubation, the cells
in lanes a, c, and d were treated with the acid. Then, the cells were
extensively washed and UV irradiated either immediately (lanes a,
b, and c) or after being incubated in EGF-free medium for an hour
at 370C (lanes d). The irradiation was performed at 40C with a UV
lamp equipped with a 340-nm glass filter for 10 min. Prior to the UV
irradiation, all the procedures were carried out under dim red light.
Then, the cells were lysed and two 40 p.1 portions of each extract
were analyzed. One of them was loaded directly on a sodium
dodecyl sulfate-polyacrylamide gel (A), and the remainder was
immunoprecipitated with anti-P-Tyr (B). The gels were subjected to
autoradiography; after that, the 175-kDa bands were cut out of the
gel and counted. Only the upper parts of the gels are shown. Panel
B is taken from a longer exposure than panel A. I, Total cell-
associated radioactivity; LI, radioactivity corresponding to 175 kDa
bands; M, relative amount of immunoprecipitated 175-kDa com-
plexes. Error bars indicate standard deviations of the mean.
3/bC
e fg h
FIG. 4. Effect of mild acid wash on the kinase activity of the
internalized EGF receptors and those located in the plasma mem-
brane. The cells were preexposed to 200 ng of EGF per ml (lanes b,
c, d, f, g, and h) or the EGF-free medium (lanes a and e) at 40C and
then either kept at low temperature (lanes a, b, c, and d) or placed
into 370C for an hour (lanes e, f, g, and h). Mfter incubation, some of
the cultures (lanes c, d, g, and h) were washed with acid. Then two
acid-washed plates were subjected to the additional incubation for
an hour either in the cold (40C) medium supplemented with 200 ng of
EGF per ml (lane d) or in the warm (370C) EGF-free medium (lane
h). The top and the bottom arrows indicate the positions of the EGF
receptor and the exogenous peptide substrate, respectively.
Moreover, an elevated level of substrate phosphorylation
was maintained during further incubation of acid-washed
cells at 370C.
All the data presented here demonstrate that the EGF
receptors are internalized in their activated state and retain
tyrosine kinase activity for at least an hour after internaliza-
tion.
We thank A. Sorokin and A. Sorkin for sharing useful information
with us. We thank the other members of our laboratory for their
helpful suggestions and constructive criticisms. Our special thanks
are to C.-H. Heldin for providing the synthetic peptide substrate.
concentration of sodium dodecyl sulfate-polyacrylamide gel
electrophoresis sample buffer. The samples were loaded
onto a gel with an 8 to 30% polyacrylamide gradient and
analyzed by electrophoresis. To facilitate the detection of
Tyr-phosphorylated proteins, the gel was then treated with 1
N KOH (6). For the exogenous substrate, we used synthetic
peptide with a phosphorylation site similar to the viral
tyrosine kinase pp6Osrc (a kind gift of C.-H. Heldin, Ludwig
Institute for Cancer Research, Uppsala Branch). The pep-
tide contains tyrosine as the single amino acid that can be
phosphorylated (4).
The results presented in Fig. 4A show that the removal of
EGF from membrane receptors completely switches off their
tyrosine kinase activity toward peptide substrate. The reex-
position of the acid-washed cells to EGF restored the
enhanced substrate phosphorylation, which indicates that
the loss of tyrosine kinase activity is not an artifact of the
acid wash. In contrast, when cells were allowed to internal-
ize EGF (Fig. 4B), the acid treatment had no significant
effect on the ability of cells to phosphorylate the substrate.
LITERATURE CITED
1. Carpenter, G., and S. Cohen. 1976. "'I1-labeled human epider-
mal growth factor (hEGF): binding, internalization and degra-
dation in human fibroblasts. J. Cell Biol. 71:159-171.
2. Carpenter, G., and S. Cohen. 1979. Epidermal growth factor.
Annu. Rev. Biochem. 48:193-216.
3. Carpentier, G. L., M. F. White, L. Orci, and R. C. Kahn. 1987.
Direct visualization of the phosphorylated epidermal growth
factor receptor during its internalization in A-431 cells. J. Cell
Biol. 105:2751-2762.
4. Cassel, D., L. J. Pike, G. A. Grant, E. G. Krehs, and L. Claser.
1983. Interaction of epidermal growth factor-dependent protein
kinase with endogenous membrane proteins and soluble peptide
substrate. J. Biol. Chem. 258:2945-2950.
5. Cohen, S., and R. A. Fava. 1985. Internalization of functional
epidermal growth factor: receptor/kinase complexes in A-431
cells. J. Biol. Chem. 260:12351-12358.
6. Cooper, J. A., and T. Hunter. 1981. Changes in protein phos-
phorylation in Rous sarcoma virus-transformed chicken embryo
cells. Mol. Cell. Biol. 1:165-178.
7. Giugni, T. D., L. C. James, and H. T. Haigler. 1985. Epidermal
growth factor stimulates tyrosine phosphorylation of specific
VOL. 10, 1990
4w- *-40 1-
is-
MOL. CELL. BIOL.
proteins in permeabilized human fibroblasts. J. Biol. Chem.
260:15081-15090.
8. Haigler, H. T., J. F. Ash, S. J. Singer, and S. Cohen. 1978.
Visualization by fluorescence of the binding and internalization
of epidermal growth factor in human carcinoma cells A-431.
Proc. Natl. Acad. Sci. USA 75:3317-3321.
9. Haigler, H. T., J. A. McKanna, and S. Cohen. 1979. Direct
visualization of the binding and internalization of a ferritin
conjugate of epidermal growth factor in human carcinoma cells
A-431. J. Cell Biol. 81:382-385.
10. Heldin, C. H., C. Betsholtz, L. Claesson-Welch, and B. Wester-
mark. 1987. Subversion of regulatory pathways in malignant
transformation. Biochim. Biophys. Acta 907:219-244.
11. Hock, R. A., E. Nexo, and M. D. HoUlenberg. 1980. Stabilization
and isolation of the human placenta receptor for epidermal
growth factor-urogastrone. J. Biol. Chem. 255:10737-10743.
12. Hopkins, C. R., K. Miller, and J. M. Beardmore. 1985. Recep-
tor-mediated endocytosis of transferrin and epidermal growth
factor receptors: a comparison of constitutive and ligand-in-
duced uptake. J. Cell Sci. 3(Suppl.):173-186.
13. Kay, D. G., W. H. Lai, M. Uchihashi, M. N. Khan, B. I. Posner,
and J. J. M. Bergeron. 1986. Epidermal growth factor receptor
kinase translocation and activation in vivo. J. Biol. Chem.
261:8473-8480.
14. King, C. S., and J. A. Cooper. 1986. Effects of protein kinase C
activation after epidermal growth factor binding on epidermal
growth factor receptor phosphorylation. J. Biol. Chem. 257:
3053-3060.
15. Krupp, M. N., D. T. ConnoBy, and M. D. Lane. 1982. Synthesis,
turnover, and down-regulation of epidermal growth factor re-
ceptors in human A431 epidermoid carcinoma cells and skin
fibroblasts. J. Biol. Chem. 257:11489-114%.
16. McKanna, J. A., H. T. Haigler, and S. Cohen. 1979. Hormone
receptor topology and dynamics: morphological analysis using
ferritin-labeled epidermal growth factor. Proc. Natl. Acad. Sci.
USA 76:5689-5693.
17. Nesterov, A. M., B. I. Rubikaite, N. A. Vinogradova, N. N.
Nikolsky, and 0. 0. Favorova. 1989. Identification of tyrosine-
phosphorylated proteins in some transformed cells using phos-
photyrosine-specific antibodies. Biol. Membr. 6:341-348.
18. Panayotou, G., and M. D. Waterfield. 1989. Cell surface recep-
tors for polypeptide hormones, growth factors and neuropep-
tides. Curr. Opinion Cell Biol. 1:167-176.
19. Pang, D. T., B. R. Sharma, J. A. Shafer, M. F. White, and C. R.
Kahn. 1985. Predominance of tyrosine phosphorylation of insu-
lin receptors during the initial response of intact cells to insulin.
J. Biol. Chem. 260:7131-7136.
20. Schlessinger, J. 1988. The epidermal growth factor as a multi-
functional allosteric protein. Biochemistry 27:3119-3123.
21. Sorkin, A., E. Kornilova, L. Teslenko, A. Sorokin, and N.
Nikolsky. 1989. Recycling of epidermal growth factor-receptor
complexes in A-431 cells. Biochim. Biophys. Acta 1011:88-96.
22. Sorkin, A. D., L. V. Teslenko, and N. N. Nikolsky. 1988. The
endocytosis of epidermal growth factor in A-431 cells: a pH of
microenvironment and the dynamics of receptor complex dis-
sociation. Exp. Cell Res. 175:192-205.
23. Stoscheck, C. M., and G. Carpenter. 1984. "Down regulation"
of EGF receptors: direct demonstration of receptor degradation
in human fibroblasts. J. Cell Biol. 98:1048-1053.
24. Sturani, E., R. Zippel, L. Toschi, L. Moreio, P. Comoglio, and
L. Albergina. 1988. Kinetics and regulation of the epidermal
growth factor receptor in intact A-431 cells. Mol. Cell. Biol.
8:1345-1351.
25. Yarden, Y., and A. UUrich. 1988. Molecular analysis of signal
transduction by growth factors. Biochemistry 27:3113-3119.
5014 NOTES

More Related Content

What's hot

Taxol and 10-deacetylbaccatinIII induce distinct changes
Taxol and 10-deacetylbaccatinIII induce distinct changesTaxol and 10-deacetylbaccatinIII induce distinct changes
Taxol and 10-deacetylbaccatinIII induce distinct changesNeesar Ahmed
 
35.Isolation and purification of endopolygalacturonase produced by Alternaria...
35.Isolation and purification of endopolygalacturonase produced by Alternaria...35.Isolation and purification of endopolygalacturonase produced by Alternaria...
35.Isolation and purification of endopolygalacturonase produced by Alternaria...Annadurai B
 
ENDOTHELIN RECEPTOR ANTAGONISTS EXHIBIT DIMINISHING POTENCY FOLLOWING INCUBAT...
ENDOTHELIN RECEPTOR ANTAGONISTS EXHIBIT DIMINISHING POTENCY FOLLOWING INCUBAT...ENDOTHELIN RECEPTOR ANTAGONISTS EXHIBIT DIMINISHING POTENCY FOLLOWING INCUBAT...
ENDOTHELIN RECEPTOR ANTAGONISTS EXHIBIT DIMINISHING POTENCY FOLLOWING INCUBAT...Kurt Naugles M.D., M.P.H.
 
03.Studies on the role of cellwall degrading enzymes of lleafblight diseases ...
03.Studies on the role of cellwall degrading enzymes of lleafblight diseases ...03.Studies on the role of cellwall degrading enzymes of lleafblight diseases ...
03.Studies on the role of cellwall degrading enzymes of lleafblight diseases ...Annadurai B
 
Studying DNA repair in Drosophila using attP site
Studying DNA repair in Drosophila using attP siteStudying DNA repair in Drosophila using attP site
Studying DNA repair in Drosophila using attP siteDavid Grossfeld
 
PharmSciShowcase-2016 TMEM35
PharmSciShowcase-2016 TMEM35PharmSciShowcase-2016 TMEM35
PharmSciShowcase-2016 TMEM35Alexandra Rezvaya
 
Research Symposium Poster (Spring - April 2014)
Research Symposium Poster (Spring - April 2014)Research Symposium Poster (Spring - April 2014)
Research Symposium Poster (Spring - April 2014)William Parker
 
Complement fixation
Complement fixationComplement fixation
Complement fixationSKYFALL
 
Nat_Chem_Biol_GPR30_2006
Nat_Chem_Biol_GPR30_2006Nat_Chem_Biol_GPR30_2006
Nat_Chem_Biol_GPR30_2006Alex Kiselyov
 

What's hot (18)

OspC PNAS
OspC PNASOspC PNAS
OspC PNAS
 
Taxol and 10-deacetylbaccatinIII induce distinct changes
Taxol and 10-deacetylbaccatinIII induce distinct changesTaxol and 10-deacetylbaccatinIII induce distinct changes
Taxol and 10-deacetylbaccatinIII induce distinct changes
 
35.Isolation and purification of endopolygalacturonase produced by Alternaria...
35.Isolation and purification of endopolygalacturonase produced by Alternaria...35.Isolation and purification of endopolygalacturonase produced by Alternaria...
35.Isolation and purification of endopolygalacturonase produced by Alternaria...
 
CREE_poster_v8
CREE_poster_v8CREE_poster_v8
CREE_poster_v8
 
ENDOTHELIN RECEPTOR ANTAGONISTS EXHIBIT DIMINISHING POTENCY FOLLOWING INCUBAT...
ENDOTHELIN RECEPTOR ANTAGONISTS EXHIBIT DIMINISHING POTENCY FOLLOWING INCUBAT...ENDOTHELIN RECEPTOR ANTAGONISTS EXHIBIT DIMINISHING POTENCY FOLLOWING INCUBAT...
ENDOTHELIN RECEPTOR ANTAGONISTS EXHIBIT DIMINISHING POTENCY FOLLOWING INCUBAT...
 
03.Studies on the role of cellwall degrading enzymes of lleafblight diseases ...
03.Studies on the role of cellwall degrading enzymes of lleafblight diseases ...03.Studies on the role of cellwall degrading enzymes of lleafblight diseases ...
03.Studies on the role of cellwall degrading enzymes of lleafblight diseases ...
 
Studying DNA repair in Drosophila using attP site
Studying DNA repair in Drosophila using attP siteStudying DNA repair in Drosophila using attP site
Studying DNA repair in Drosophila using attP site
 
Reboll-2012-Compl
Reboll-2012-ComplReboll-2012-Compl
Reboll-2012-Compl
 
PharmSciShowcase-2016 TMEM35
PharmSciShowcase-2016 TMEM35PharmSciShowcase-2016 TMEM35
PharmSciShowcase-2016 TMEM35
 
Mekuria's poster
Mekuria's posterMekuria's poster
Mekuria's poster
 
Research Symposium Poster (Spring - April 2014)
Research Symposium Poster (Spring - April 2014)Research Symposium Poster (Spring - April 2014)
Research Symposium Poster (Spring - April 2014)
 
Ch06
Ch06Ch06
Ch06
 
Npy
NpyNpy
Npy
 
Npy final paper
Npy final paperNpy final paper
Npy final paper
 
Complement fixation
Complement fixationComplement fixation
Complement fixation
 
Nat_Chem_Biol_GPR30_2006
Nat_Chem_Biol_GPR30_2006Nat_Chem_Biol_GPR30_2006
Nat_Chem_Biol_GPR30_2006
 
Histamine
HistamineHistamine
Histamine
 
The Effect of Losartan on Deformities Occurring in Brain Tissue Craniectomy
The Effect of Losartan on Deformities Occurring in Brain Tissue CraniectomyThe Effect of Losartan on Deformities Occurring in Brain Tissue Craniectomy
The Effect of Losartan on Deformities Occurring in Brain Tissue Craniectomy
 

Similar to MCB

IRJET- Subcellular Localization of Transmembrane E-cadherin-GFP Fusion Pr...
IRJET-  	  Subcellular Localization of Transmembrane E-cadherin-GFP Fusion Pr...IRJET-  	  Subcellular Localization of Transmembrane E-cadherin-GFP Fusion Pr...
IRJET- Subcellular Localization of Transmembrane E-cadherin-GFP Fusion Pr...IRJET Journal
 
Schindler and Schekman 2009 PNAS
Schindler and Schekman 2009 PNASSchindler and Schekman 2009 PNAS
Schindler and Schekman 2009 PNASAdam Schindler
 
ReedWoyda_Introducing Green Fluorescence Into Homo sapiens And Escherichia Co...
ReedWoyda_Introducing Green Fluorescence Into Homo sapiens And Escherichia Co...ReedWoyda_Introducing Green Fluorescence Into Homo sapiens And Escherichia Co...
ReedWoyda_Introducing Green Fluorescence Into Homo sapiens And Escherichia Co...Reed Woyda
 
Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange
Structural basis of omalizumab therapy and omalizumab-mediated IgE exchangeStructural basis of omalizumab therapy and omalizumab-mediated IgE exchange
Structural basis of omalizumab therapy and omalizumab-mediated IgE exchangeGul Muneer
 
INFECTION AND IMMUNrrY, June 1977, P. 734-737Copyright © 197.docx
INFECTION AND IMMUNrrY, June 1977, P. 734-737Copyright © 197.docxINFECTION AND IMMUNrrY, June 1977, P. 734-737Copyright © 197.docx
INFECTION AND IMMUNrrY, June 1977, P. 734-737Copyright © 197.docxjaggernaoma
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...daranisaha
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...semualkaira
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...semualkaira
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...semualkaira
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...eshaasini
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...JohnJulie1
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...NainaAnon
 
ENEBC Vertical Poster (2)
ENEBC Vertical Poster (2)ENEBC Vertical Poster (2)
ENEBC Vertical Poster (2)Ethan Barach
 
Epidermal growth factor and its receptor tyrosine kinase
Epidermal growth factor and its receptor tyrosine kinaseEpidermal growth factor and its receptor tyrosine kinase
Epidermal growth factor and its receptor tyrosine kinaseGedion Yilma
 
i1552-5783-57-2-372
i1552-5783-57-2-372i1552-5783-57-2-372
i1552-5783-57-2-372Ryo Iwata
 
Commercial Application of Anoectochilus formosanus: Immunomodulating Activities
Commercial Application of Anoectochilus formosanus: Immunomodulating ActivitiesCommercial Application of Anoectochilus formosanus: Immunomodulating Activities
Commercial Application of Anoectochilus formosanus: Immunomodulating ActivitiesCây thuốc Việt
 
Poster Monterey 2005
Poster Monterey 2005Poster Monterey 2005
Poster Monterey 2005Anna Öberg
 
Specific enzymatic amplification of DNA in vitro: The polymerase chain reaction
Specific enzymatic amplification of DNA in vitro: The polymerase chain reactionSpecific enzymatic amplification of DNA in vitro: The polymerase chain reaction
Specific enzymatic amplification of DNA in vitro: The polymerase chain reactionJosé Luis Moreno Garvayo
 

Similar to MCB (20)

IRJET- Subcellular Localization of Transmembrane E-cadherin-GFP Fusion Pr...
IRJET-  	  Subcellular Localization of Transmembrane E-cadherin-GFP Fusion Pr...IRJET-  	  Subcellular Localization of Transmembrane E-cadherin-GFP Fusion Pr...
IRJET- Subcellular Localization of Transmembrane E-cadherin-GFP Fusion Pr...
 
Schindler and Schekman 2009 PNAS
Schindler and Schekman 2009 PNASSchindler and Schekman 2009 PNAS
Schindler and Schekman 2009 PNAS
 
ReedWoyda_Introducing Green Fluorescence Into Homo sapiens And Escherichia Co...
ReedWoyda_Introducing Green Fluorescence Into Homo sapiens And Escherichia Co...ReedWoyda_Introducing Green Fluorescence Into Homo sapiens And Escherichia Co...
ReedWoyda_Introducing Green Fluorescence Into Homo sapiens And Escherichia Co...
 
Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange
Structural basis of omalizumab therapy and omalizumab-mediated IgE exchangeStructural basis of omalizumab therapy and omalizumab-mediated IgE exchange
Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange
 
SSEF Report 5
SSEF Report 5SSEF Report 5
SSEF Report 5
 
INFECTION AND IMMUNrrY, June 1977, P. 734-737Copyright © 197.docx
INFECTION AND IMMUNrrY, June 1977, P. 734-737Copyright © 197.docxINFECTION AND IMMUNrrY, June 1977, P. 734-737Copyright © 197.docx
INFECTION AND IMMUNrrY, June 1977, P. 734-737Copyright © 197.docx
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
 
Bio Final lab paper
Bio Final lab paperBio Final lab paper
Bio Final lab paper
 
ENEBC Vertical Poster (2)
ENEBC Vertical Poster (2)ENEBC Vertical Poster (2)
ENEBC Vertical Poster (2)
 
Epidermal growth factor and its receptor tyrosine kinase
Epidermal growth factor and its receptor tyrosine kinaseEpidermal growth factor and its receptor tyrosine kinase
Epidermal growth factor and its receptor tyrosine kinase
 
i1552-5783-57-2-372
i1552-5783-57-2-372i1552-5783-57-2-372
i1552-5783-57-2-372
 
Commercial Application of Anoectochilus formosanus: Immunomodulating Activities
Commercial Application of Anoectochilus formosanus: Immunomodulating ActivitiesCommercial Application of Anoectochilus formosanus: Immunomodulating Activities
Commercial Application of Anoectochilus formosanus: Immunomodulating Activities
 
Poster Monterey 2005
Poster Monterey 2005Poster Monterey 2005
Poster Monterey 2005
 
Specific enzymatic amplification of DNA in vitro: The polymerase chain reaction
Specific enzymatic amplification of DNA in vitro: The polymerase chain reactionSpecific enzymatic amplification of DNA in vitro: The polymerase chain reaction
Specific enzymatic amplification of DNA in vitro: The polymerase chain reaction
 

More from Alexandre "Sasha" Nesterov (14)

TRPV Neuron 2015
TRPV Neuron 2015TRPV Neuron 2015
TRPV Neuron 2015
 
Archives
ArchivesArchives
Archives
 
JBC1
JBC1JBC1
JBC1
 
PNAS
PNASPNAS
PNAS
 
EMBO
EMBOEMBO
EMBO
 
Oncogene1.PDF
Oncogene1.PDFOncogene1.PDF
Oncogene1.PDF
 
JBC2
JBC2JBC2
JBC2
 
Cancer Research 2
Cancer Research 2Cancer Research 2
Cancer Research 2
 
Skin_whiteners_patent_2015
Skin_whiteners_patent_2015Skin_whiteners_patent_2015
Skin_whiteners_patent_2015
 
Drug Fut
Drug FutDrug Fut
Drug Fut
 
CPB-UP302-Publication
CPB-UP302-PublicationCPB-UP302-Publication
CPB-UP302-Publication
 
JBS 2010
JBS 2010JBS 2010
JBS 2010
 
PNAS_CCR5_drug_binding
PNAS_CCR5_drug_bindingPNAS_CCR5_drug_binding
PNAS_CCR5_drug_binding
 
Nesterov et al_Science_signaling_2015
Nesterov et al_Science_signaling_2015Nesterov et al_Science_signaling_2015
Nesterov et al_Science_signaling_2015
 

MCB

  • 1. Vol. 10, No. 9MOLECULAR AND CELLULAR BIOLOGY, Sept. 1990, p. 5011-5014 0270-7306/90/095011-04$02.00/0 Functional State of the Epidermal Growth Factor-Receptor Complexes during Their Internalization in A-431 Cells ALEXANDER NESTEROV,* GALINA RESHETNIKOVA, NINA VINOGRADOVA, AND NIKOLAY NIKOLSKY Institute of Cytology of the Academy of Sciences of the USSR, Tikhoretsky pr. 4, Leningrad 194064, USSR Received 13 February 1990/Accepted 21 June 1990 Functional state of internalized epidermal growth factor (EGF) receptor in A431 cells has been studied. The use of photoaffinity [12"I]EGF derivative allowed us to establish that inside the cell the EGF retains its connection with the receptor. With the help of polyclonal antibodies to phosphotyrosine, it has been shown that EGF-receptor complexes maintain their phosphorylated state during internalization. The internalized EGF receptor kinase as well as that localized in the plasma membrane appeared to be able to phosphorylate synthetic peptide substrate introduced into the cell. The epidermal growth factor (EGF) receptor is a 170- kilodalton (kDa) integral membrane glycoprotein containing cytosol-oriented tyrosine-specific kinase (for a review, see reference 18). EGF binding stimulates receptor tyrosine kinase, resulting in both receptor and substrate phosphory- lation (for a review, see reference 10). There is a lot of data showing that receptor kinase activity plays an important role in the transmission of mitogenic signal (for a review, see references 20 and 25). After EGF binding, the ligand-receptor complexes are rapidly internalized; they are then delivered to various endosomal structures and, finally, degraded within lyso- somes (8, 9, 12, 21, 22). The role of the internalization process in triggering the biochemical reactions leading to DNA synthesis so far remains obscure. To elucidate this question, the functional state of internalized EGF receptor should be determined. Whether the EGF receptors retain their functional activity during the translocation from plasma membrane into endo- somal compartment is yet to be clarified. Thus, the presence of active EGF receptor in the fractions of intracellular components isolated from homogenates of A-431 cells (5) and rat liver cells (13) has been shown. On the other hand, from the results of experiments on intact A-431 cells, Sturani and co-workers concluded that internalized EGF receptors failed to maintain the phosphorylated state of tyrosine resi- dues (24). In this study, we compared the functional state of internalized and membrane-localized EGF-receptor com- plexes by using two experimental approaches: (i) cell ex- posure to EGF at low temperature, which is known to completely block internalization (1) and (ii) removal of surface-bound EGF by cell treatment with weak acid buffer (50 mM sodium acetate [pH 4.5 to 5.0] containing 150 mM NaCl). To identify phosphotyrosine-containing proteins, we have used affinity-purified polyclonal antibody to phospho- tyrosine (anti-P-Tyr). As has been established previously, the major phosphoprotein interacting with this antibody in the EGF-stimulated A-431 cells is the EGF receptor (17). Effect of mild acid wash on EGF receptor Tyr phosphory- lation. In two parallel series of experiments, the cells were preincubated with EGF at 4°C and then placed at 37 or 4°C for an hour. During this period of incubation at 37°C, from 60 to 75% of cell-associated [125I]EGF was found to be inter- * Corresponding author. nalized (data not shown). After the incubation with EGF, some ofthe cultures were subjected to acid treatment. In the first series of experiments (Fig. 1), the cells were metaboli- cally labeled with [32P]orthophosphate and Tyr-phosphory- lated receptors were detected by immunoprecipitation with anti-P-Tyr, while in the second series of experiments the receptors were detected by immunofluorescence staining (Fig. 2). Sodium dodecyl sulfate-polyacrylamide gel electro- phoresis of immunoprecipitated proteins has shown that at 4°C, EGF markedly stimulates Tyr phosphorylation of a 170-kDa protein corresponding to the known molecular mass of EGF receptor (2). Under such conditions, immunostain- ing is observed along the cell margins, which is a typical pattern for the distribution of membrane receptors (8, 21, 22). Removal ofthe surface-bound EGF by acid treatment of the cells incubated with EGF at 4°C resulted in rapid receptor dephosphorylation. In contrast, in the case of incubation of cells at 37°C, when internalization took place, such acid treatment did not result in any significant decre- ment of phosphotyrosine content in the receptor molecule, which indicates that during internalization the receptors remain Tyr phosphorylated. Immunofluorescence analysis shows that inside the cell, phosphorylated receptors are mainly concentrated in the juxtanuclear area which has earlier been identified as the para-Golgi region (22). Photoaffinity labeling of the EGF receptor. To prepare the photoaffinity EGF derivative, [1251I]EGF was coupled to the heterobifunctional reagent N-5-azido-2-nitrobenzoyloxysuc- cinimide (Sigma Chemical Co.) as described by Hock and co-workers (11). The cells were allowed to internalize pho- toaffinity [125I]EGF, and then some of the cultures were subjected to acid treatment. At the end of the procedure described in detail in the legend to Fig. 3, the cells were UV irradiated to provoke ['25I]EGF-receptor covalent coupling. After that, the cells were solubilized and two equivalent portions of each extract were analyzed. One of them was immunoprecipitated with anti-P-Tyr, and then both the im- munoprecipitate and the total extract were processed by electrophoresis. Radioactivity corresponding to 175-kDa bands and total cell-associated radioactivity were measured. The immunoprecipitation efficiency determined by the addi- tional immunoprecipitation from the same extract with a new portion of anti-P-Tyr appeared to be equal to 90% (data not shown). In control experiments, when the internalization was blocked by low temperature (Fig. 3, lanes a), the acid treatment resulted in a strong decrease in the radioactivity of 5011
  • 2. MOL. CELL. BIOL. 40C 37°C 4°C 370C a bc d e f * 4113-170 FIG. 1. Effect of mild acid wash on the phosphotyrosine content in internalized EGF receptors and those located in the plasma membrane. Cells were labeled with [32P]orthophosphate and ex- posed to 200 ng of EGF per ml (lanes b, c, e, and f) or EGF-free medium (lanes a and d) for an hour at 4°C. Then, some of the cultures in the same medium were placed at 37°C for an hour (lanes d, e, and f), while the others were left at 4°C (lanes a, b, and c). After incubation, the cells were either immediately extracted (lanes a, b, d, and e) or washed with the acid (lanes c and f). Phosphotyrosine- containing proteins were immunoprecipitated with 20 ,ug of anti-P- Tyr, separated by sodium dodecyl sulfate-polyacrylamide gel elec- trophoresis, and identified by autoradiography. Molecular size, in kilodaltons, is shown on the right. 175-kDa bands. The data suggest that lack of sensitivity of photoaffinity [1251I]EGF to acid treatment indicates its intra- cellular location and is not due to spontaneous covalent ligand-receptor coupling. Using photoaffinity [1251]EGF derivative, we analyzed EGF-receptor interactions directly within endosomes. Com- parison of lanes b and c in Fig. 3 shows that acid treatment results in the same decrease in the radioactivity of both 175-kDa bands and in the total cell-associated radioactivity. These results show that the photoaffinity [1251]EGF attach to the receptors in endosomes as effectively as in plasma membrane, which indicates that during internalization no significant dissociation of ligand-receptor complexes occurs. The data obtained are in agreement with electron micros- copy observations (3, 16) and our previous results on cells permeabilized with detergent (21). It should be noted that the slow degradation kinetics of EGF-receptor complexes is a peculiarity of A-431 cells (15). For instance, in human diploid fibroblasts, receptor degradation is much more rapid (23). The immunoprecipitation of covalent [125I]EGF-receptor complexes has shown that only about 15% of them are capable of interacting with anti-P-Tyr, which points to functional heterogeneity of the EGF receptor population in A-431 cells. King and Cooper (14), as well as Sturani and co-workers (24), came to the same conclusion by using other experimental approaches. As has been found previously for the insulin receptor (19), it can be assumed that there are at least two EGF receptor subpopulations which differ in phosphorylation state. The fact that the percentage of ty- rosine-phosphorylated receptors remains unchanged during internalization shows that inside the cell, the receptors are not affected by dephosphorylation. FIG. 2. Immunofluorescent staining of A-431 cells with anti-P- Tyr. Cells on cover slips were incubated with EGF and washed as described in the legend to Fig. 1. At the end of the procedure, cells were fixed with 4% formaldehyde, permeabilized with 0.1% Triton X-100, and stained with anti-P-Tyr. The second antibodies used were fluorescein isothiocyanate-conjugated goat anti-rabbit immu- noglobulin G. Lanes in Fig. 1 correspond to the panels in Fig. 2. Bar, 50 pm. Evaluation of receptor kinase activity. In the experiments on the intact cells, the protein kinase activity of internalized EGF receptor was indirectly estimated by the phosphoty- rosine content in the receptor molecule (3, 24). However, the amount of phosphorylated receptors depends on at least two additional factors which can vary during the internalization: (i) the tyrosine phosphatase activity in the cell interior and (ii) the competition for tyrosine kinase between different intracellular substrates, on one side, and receptor autophos- phorylation sites, on the other. Consequently, the direct method should be employed to evaluate the activity of the EGF receptor tyrosine kinase during endocytosis. For this purpose, the exogenous tyrosine kinase substrate and [-y-32P]ATP were introduced by mild digitonine permeabili- zation into the cells treated as described in the legend to Fig. 4. After the cells were treated, the EGF-stimulated tyrosine kinase activity was assayed. The reaction was carried out as described by Giugni and co-workers (7), except that the reaction mixture was supplemented with synthetic peptide. Briefly, the phosphorylation reaction was initiated by the addition of reaction mixture containing 50 ,uM [-y-32P]ATP, the synthetic peptide substrate for tyrosine kinase (1 mg/ml), and 0.01% digitonine. Phosphorylation was allowed to pro- ceed for 10 min at 4°C, after which the reaction was terminated by the addition of an equal volume of a double 5012 NOTES
  • 3. VOL.10,1990~~~~~~~~~~~~~~~~~~NOTES5013 Pc A IL --_J I a -- B a b cd Ibe--c 1 d I a.- Snesad~f '.4 0 -;50.4) .0 C; a b a d FIG. 3. Photoaffinity labeling of EGF receptor. The cells were preexposed to photoaffinity [1251]IEGF (200 ng/ml) at 40C and then placed at 370C for an hour (lanes b, c, and d), while the control cultures (lanes a) were left at 40C. At the end of incubation, the cells in lanes a, c, and d were treated with the acid. Then, the cells were extensively washed and UV irradiated either immediately (lanes a, b, and c) or after being incubated in EGF-free medium for an hour at 370C (lanes d). The irradiation was performed at 40C with a UV lamp equipped with a 340-nm glass filter for 10 min. Prior to the UV irradiation, all the procedures were carried out under dim red light. Then, the cells were lysed and two 40 p.1 portions of each extract were analyzed. One of them was loaded directly on a sodium dodecyl sulfate-polyacrylamide gel (A), and the remainder was immunoprecipitated with anti-P-Tyr (B). The gels were subjected to autoradiography; after that, the 175-kDa bands were cut out of the gel and counted. Only the upper parts of the gels are shown. Panel B is taken from a longer exposure than panel A. I, Total cell- associated radioactivity; LI, radioactivity corresponding to 175 kDa bands; M, relative amount of immunoprecipitated 175-kDa com- plexes. Error bars indicate standard deviations of the mean. 3/bC e fg h FIG. 4. Effect of mild acid wash on the kinase activity of the internalized EGF receptors and those located in the plasma mem- brane. The cells were preexposed to 200 ng of EGF per ml (lanes b, c, d, f, g, and h) or the EGF-free medium (lanes a and e) at 40C and then either kept at low temperature (lanes a, b, c, and d) or placed into 370C for an hour (lanes e, f, g, and h). Mfter incubation, some of the cultures (lanes c, d, g, and h) were washed with acid. Then two acid-washed plates were subjected to the additional incubation for an hour either in the cold (40C) medium supplemented with 200 ng of EGF per ml (lane d) or in the warm (370C) EGF-free medium (lane h). The top and the bottom arrows indicate the positions of the EGF receptor and the exogenous peptide substrate, respectively. Moreover, an elevated level of substrate phosphorylation was maintained during further incubation of acid-washed cells at 370C. All the data presented here demonstrate that the EGF receptors are internalized in their activated state and retain tyrosine kinase activity for at least an hour after internaliza- tion. We thank A. Sorokin and A. Sorkin for sharing useful information with us. We thank the other members of our laboratory for their helpful suggestions and constructive criticisms. Our special thanks are to C.-H. Heldin for providing the synthetic peptide substrate. concentration of sodium dodecyl sulfate-polyacrylamide gel electrophoresis sample buffer. The samples were loaded onto a gel with an 8 to 30% polyacrylamide gradient and analyzed by electrophoresis. To facilitate the detection of Tyr-phosphorylated proteins, the gel was then treated with 1 N KOH (6). For the exogenous substrate, we used synthetic peptide with a phosphorylation site similar to the viral tyrosine kinase pp6Osrc (a kind gift of C.-H. Heldin, Ludwig Institute for Cancer Research, Uppsala Branch). The pep- tide contains tyrosine as the single amino acid that can be phosphorylated (4). The results presented in Fig. 4A show that the removal of EGF from membrane receptors completely switches off their tyrosine kinase activity toward peptide substrate. The reex- position of the acid-washed cells to EGF restored the enhanced substrate phosphorylation, which indicates that the loss of tyrosine kinase activity is not an artifact of the acid wash. In contrast, when cells were allowed to internal- ize EGF (Fig. 4B), the acid treatment had no significant effect on the ability of cells to phosphorylate the substrate. LITERATURE CITED 1. Carpenter, G., and S. Cohen. 1976. "'I1-labeled human epider- mal growth factor (hEGF): binding, internalization and degra- dation in human fibroblasts. J. Cell Biol. 71:159-171. 2. Carpenter, G., and S. Cohen. 1979. Epidermal growth factor. Annu. Rev. Biochem. 48:193-216. 3. Carpentier, G. L., M. F. White, L. Orci, and R. C. Kahn. 1987. Direct visualization of the phosphorylated epidermal growth factor receptor during its internalization in A-431 cells. J. Cell Biol. 105:2751-2762. 4. Cassel, D., L. J. Pike, G. A. Grant, E. G. Krehs, and L. Claser. 1983. Interaction of epidermal growth factor-dependent protein kinase with endogenous membrane proteins and soluble peptide substrate. J. Biol. Chem. 258:2945-2950. 5. Cohen, S., and R. A. Fava. 1985. Internalization of functional epidermal growth factor: receptor/kinase complexes in A-431 cells. J. Biol. Chem. 260:12351-12358. 6. Cooper, J. A., and T. Hunter. 1981. Changes in protein phos- phorylation in Rous sarcoma virus-transformed chicken embryo cells. Mol. Cell. Biol. 1:165-178. 7. Giugni, T. D., L. C. James, and H. T. Haigler. 1985. Epidermal growth factor stimulates tyrosine phosphorylation of specific VOL. 10, 1990 4w- *-40 1- is-
  • 4. MOL. CELL. BIOL. proteins in permeabilized human fibroblasts. J. Biol. Chem. 260:15081-15090. 8. Haigler, H. T., J. F. Ash, S. J. Singer, and S. Cohen. 1978. Visualization by fluorescence of the binding and internalization of epidermal growth factor in human carcinoma cells A-431. Proc. Natl. Acad. Sci. USA 75:3317-3321. 9. Haigler, H. T., J. A. McKanna, and S. Cohen. 1979. Direct visualization of the binding and internalization of a ferritin conjugate of epidermal growth factor in human carcinoma cells A-431. J. Cell Biol. 81:382-385. 10. Heldin, C. H., C. Betsholtz, L. Claesson-Welch, and B. Wester- mark. 1987. Subversion of regulatory pathways in malignant transformation. Biochim. Biophys. Acta 907:219-244. 11. Hock, R. A., E. Nexo, and M. D. HoUlenberg. 1980. Stabilization and isolation of the human placenta receptor for epidermal growth factor-urogastrone. J. Biol. Chem. 255:10737-10743. 12. Hopkins, C. R., K. Miller, and J. M. Beardmore. 1985. Recep- tor-mediated endocytosis of transferrin and epidermal growth factor receptors: a comparison of constitutive and ligand-in- duced uptake. J. Cell Sci. 3(Suppl.):173-186. 13. Kay, D. G., W. H. Lai, M. Uchihashi, M. N. Khan, B. I. Posner, and J. J. M. Bergeron. 1986. Epidermal growth factor receptor kinase translocation and activation in vivo. J. Biol. Chem. 261:8473-8480. 14. King, C. S., and J. A. Cooper. 1986. Effects of protein kinase C activation after epidermal growth factor binding on epidermal growth factor receptor phosphorylation. J. Biol. Chem. 257: 3053-3060. 15. Krupp, M. N., D. T. ConnoBy, and M. D. Lane. 1982. Synthesis, turnover, and down-regulation of epidermal growth factor re- ceptors in human A431 epidermoid carcinoma cells and skin fibroblasts. J. Biol. Chem. 257:11489-114%. 16. McKanna, J. A., H. T. Haigler, and S. Cohen. 1979. Hormone receptor topology and dynamics: morphological analysis using ferritin-labeled epidermal growth factor. Proc. Natl. Acad. Sci. USA 76:5689-5693. 17. Nesterov, A. M., B. I. Rubikaite, N. A. Vinogradova, N. N. Nikolsky, and 0. 0. Favorova. 1989. Identification of tyrosine- phosphorylated proteins in some transformed cells using phos- photyrosine-specific antibodies. Biol. Membr. 6:341-348. 18. Panayotou, G., and M. D. Waterfield. 1989. Cell surface recep- tors for polypeptide hormones, growth factors and neuropep- tides. Curr. Opinion Cell Biol. 1:167-176. 19. Pang, D. T., B. R. Sharma, J. A. Shafer, M. F. White, and C. R. Kahn. 1985. Predominance of tyrosine phosphorylation of insu- lin receptors during the initial response of intact cells to insulin. J. Biol. Chem. 260:7131-7136. 20. Schlessinger, J. 1988. The epidermal growth factor as a multi- functional allosteric protein. Biochemistry 27:3119-3123. 21. Sorkin, A., E. Kornilova, L. Teslenko, A. Sorokin, and N. Nikolsky. 1989. Recycling of epidermal growth factor-receptor complexes in A-431 cells. Biochim. Biophys. Acta 1011:88-96. 22. Sorkin, A. D., L. V. Teslenko, and N. N. Nikolsky. 1988. The endocytosis of epidermal growth factor in A-431 cells: a pH of microenvironment and the dynamics of receptor complex dis- sociation. Exp. Cell Res. 175:192-205. 23. Stoscheck, C. M., and G. Carpenter. 1984. "Down regulation" of EGF receptors: direct demonstration of receptor degradation in human fibroblasts. J. Cell Biol. 98:1048-1053. 24. Sturani, E., R. Zippel, L. Toschi, L. Moreio, P. Comoglio, and L. Albergina. 1988. Kinetics and regulation of the epidermal growth factor receptor in intact A-431 cells. Mol. Cell. Biol. 8:1345-1351. 25. Yarden, Y., and A. UUrich. 1988. Molecular analysis of signal transduction by growth factors. Biochemistry 27:3113-3119. 5014 NOTES